TY - JOUR T1 - Colchicine in Behçet Syndrome: A Longterm Survey of Patients in a Controlled Trial JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.130847 SP - jrheum.130847 AU - Vedat Hamuryudan AU - Gulen Hatemi AU - Koray Tascilar AU - Sebahattin Yurdakul AU - Cem Mat AU - Yilmaz Ozyazgan AU - Emire Seyahi AU - Serdal Ugurlu AU - Hasan Yazici Y1 - 2014/02/15 UR - http://www.jrheum.org/content/early/2014/02/12/jrheum.130847.abstract N2 - Objective To test the hypothesis that colchicine use during early disease decreases immunosuppressive use in Behçet syndrome (BS) in the long term. Methods Patients with BS who participated in a double-blind, placebo-controlled trial of colchicine 16.6 ± 1.1 years ago were evaluated for immunosuppressive use during the posttrial period. Results We could contact 90/116 patients; 28 (31%) received immunosuppressives during the posttrial period, 14 being from the colchicine arm. Posttrial colchicine use and cumulative duration were similar between patients who received immunosuppressives and those who did not. Conclusion Continuous use of colchicine, even when initiated at an early disease stage, does not seem to decrease the use of immunosuppressives in the long term. ER -